/ Print /

Pharmacy Best Practices

Medication adherence: High tech still needs a personal touchWhere do the capabilities of healthcare technology end and the need for the human hand begin to deliver top value for managed care executives?
Three ways technology is improving the pharmaceutical industryTechnology in pharmacy is leading to improved safety, accountability, and efficiency.
Five ways you can help fight the opioid epidemicThe opioid crisis in the U.S. is a multidimensional problem requiring a multistakeholder solution.
Walgreens-Prime alliance: A new breed pharmacy strategy?This model, touted as “next-generation,” combines retail and specialty and mail services and PBM along with immediate care clinics.
Specialty pharmaceuticals: Solving top challenges
Specialty pharmaceuticals: Solving top challengesManaged Healthcare Executive recently invited a panel of experts representing different sectors of the healthcare industry to explore specialty pharmaceutical challenges and identify potential solutions.
Antidepressant drug pipeline: What to know
Antidepressant drug pipeline: What to knowThere are promising developments in the pipeline for patients with treatment-resistant depression.
Top 4 pharmacy trends healthcare executives should watch
Top 4 pharmacy trends healthcare executives should watchManaged Healthcare Executive conducted its first-ever managed care pharmacy survey during the second quarter of 2016 in partnership with Access Market Intelligence. Here’s a look at some of the key findings, with experts weighing in on the results.
How three hospitals are countering rising drug prices
How three hospitals are countering rising drug pricesRising drug costs are a big problem for all healthcare systems in the U.S. Here’s how three hospitals are addressing the problem.
Four things executives need to know to combat rising drug spendExecutives need to ask themselves four key questions to mitigate the negative impact of rising drug costs.
Biosimilar drugs appear comparable to brand-name counterpartsSystematic review provides comprehensive first look at TNF-alpha biosimilar treatments.